presented in the Notes to consolidated financial statements No 2. The Company and its subsidiaries had total revenue and profit of baht 15,333.29 million and baht 1,266.52 million respectively, a decrease of
) -34.6 Cost of service 2,591 2,393 198 8.3 Selling and administrative expenses 303 276 27 9.8 Finance cost 328 312 16 5.1 Interest expense from the MRT Purple Line Project 94 108 (14) -13.0 Total expenses
ENDED DECEMBER 31, 2017 1. Operating performance as compar ison analysis between those in the year 2017 and 2016 in consolidated financial statement. Description 2017 2016 Increase (Decrease) Amount
, 2018 1. Analysis of operation results for year 2018 in compar ison with those for year 2018 (from the consolidated financial statements) Items 2018 2017 Increased (Decreased) Amount % 1.1 Revenues from
management in Thailand. The performance of the Company and the Company’s subsidiaries for the second quarter of 2019, the consolidated financial statement showed a net profit of 148.5 million baht, which was
Performance Summary – by business Revenues by business THB’000 Consolidated Q2/2019 Q2/2019 ∆% Distributor of medical devices and equipment 451,157 415,547 9% Margin 163,818 160,282 2% Beauty services 33,424
results of the Company and its subsidiaries for of the second quarter of the year 2019, ended 30 June 2019 as follows: Statement of comprehensive income Statement of comprehensive income Consolidated
23.73% 7. Mrs. Pranee Parksook Senior Vice President, Finance Department 0.10% Director 0.05% (3) General Explanation regarding Nature of the Connected Transaction Details of the connected transaction are
Company’s subsidiaries for the second quarter of 2018, the consolidated financial statement showed a net profit of 119.9 million baht, which was a lower from the second quarter of 2017 3.9 percent. This
of 34 branches will be received after 1 January 2020. 2. Financial Performance Summary – by business Revenues by business THB’000 Consolidated Q2/2018 Q2/2017 ∆% Distributor of medical devices and